| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
14159, L.P. last filed a Form 4 in January 2016, as Director, 10% Owner at ACAD.
At the last filing, the largest reported position was 20,278,008 shares of ACAD. Net of sales, the ACAD filings show accumulation of 2,586,206 shares.
14159, L.P. has 1 Form 4 filing on record in January 2016, as Director, 10% Owner at Acadia Pharmaceuticals (ACAD), 2016.
The 2 reported transactions were 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $75.0M and no sales.
The only open-market purchase was 2,586,206 shares of ACAD at an average $29.00 on January 7, 2016, about $75.0M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2016 | ACAD Acadia Pharmaceuticals Inc | Director, 10% Owner | Buy | 2,586,206 | $29.00 | $74,999,974.00 | +14.6% |